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Driven by the need to engineer robust surface coatings for medical devices to
prevent infection and sepsis, incorporation of nanoparticles has surfaced as a
promising avenue to enhance non-fouling efficacy. Microbial synthesis of such nanoscale
metallic structures is of substantive interest as this can offer an eco-friendly, cost-
effective, and sustainable route for further development. Here we present a Mucor
hiemalis-derived fungal route for synthesis of silver nanoparticles, which display
significant antimicrobial properties when tested against six pathological bacterial
strains (Klebsiella pneumoniae, Pseudomonas brassicacearum, Aeromonas hydrophila,
Escherichia coli, Bacillus cereus, and Staphylococcus aureus) and three pathological
fungal strains (Candida albicans, Fusarium oxysporum, and Aspergillus flavus).
These antimicrobial attributes were comparable to those of established antibiotics
(streptomycin, tetracycline, kanamycin, and rifampicin) and fungicides (amphotericin
B, fluconazole, and ketoconazole), respectively. Importantly, these nanoparticles show
significant synergistic characteristics when combined with the antibiotics and fungicides
to offer substantially greater resistance to microbial growth. The blend of antibacterial
and antifungal properties, coupled with their intrinsic “green” and facile synthesis,
makes these biogenic nanoparticles particularly attractive for future applications in
nanomedicine ranging from topical ointments and bandages for wound healing to
coated stents.
Keywords: silver nanoparticles, Mucor hiemalis, antibacterial activity, antifungal activity, green synthesis
INTRODUCTION
Microbial infections have presented a persistent threat to human health with infections emanating
in traumatic and surgical wounds and burns posing an overarching challenge, despite the
pioneering breakthroughs in antibiotics and antiseptics (Murray, 2007). Excessive antibiotic use
(and misuse) has resulted in growing resistance to such treatment strategies (MacGowan, 2001;
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Hancock, 2007). Notably, the outbreak of antibiotic-resistance
has resulted in an unprecedented rise in nosocomial infections,
such as urinary tract infections, pneumonia, and bloodstream
infections. In the United States alone, roughly 1.7 million
estimated nosocomial infections, primarily from bacteria and
fungi, are responsible for 99,000 deaths each year (Klevens
et al., 2007). Owing to this increased resistance of several
pathogenic bacteria against antibiotics, considerable attention has
been focused on developing new treatment modalities featuring
alternative antibacterial agents (Aziz et al., 2014; Manikprabhu
and Lingappa, 2014; Teillant et al., 2015). In this milieu, metallic
silver, especially in the form of nanoparticle and nanostructured
substrates, has received considerable traction for antibacterial
activity due to its unique physiochemical properties (Husain
et al., 2015; Prasad et al., 2016). While the antimicrobial
activity of silver has been known for several centuries (Demling
and De Santi, 2001), recent developments in the field of
nanocrystalline silver have led to renewed interest (Paddock et al.,
2007).
Recent reports in the literature have illustrated the bactericidal
activity of silver nanoparticles (AgNPs; Rai et al., 2009; Aziz
et al., 2015). Ingle et al. (2008) have shown that AgNPs
exhibited significant antimicrobial activity against Escherichia
coli and multidrug resistant Staphylococcus aureus, while Pal
et al. (2007) have studied the impact of nanoparticle architecture
on the antibacterial activity against E. coli. Importantly, AgNPs
is also found to disrupt the formation of biofilm (Husain
et al., 2015), which exhibits an intricate structure composed
of bacterial cells embedded in an matrix of extracellular
polymeric substances and serves as an effective barrier against
antibiotics and the host immune system. Bacteria residing in
biofilms are observed to be significantly more resistant to
antibacterial compounds with respect to their planktonic form
and therefore the ability of AgNPs to interfere with bacterial
biofilms affords a key opportunity for biomedical applications.
The most notable application of AgNPs in the medical industry
include topical ointments (Tian et al., 2007; Hebeisha et al.,
2014), while newly devised AgNPs-coated dressings also appear
promising for the management of wounds and infections
(Maneerung et al., 2008; Wilkinson et al., 2011; Nam et al.,
2015).
To meet the synthesis demands for topical ointments and
wound dressings, numerous physical and chemical routes
are commonly used to produce a palette of controlled and
tailored Ag nanostructures (Xie et al., 2007). However, the
chemical reagents used normally for nanoparticles’ synthesis
and stabilization are toxic and lead to non-ecofriendly by-
products (Ingale and Chaudhari, 2013; Tripathi et al., 2016).
Alternately, investigators have also proposed the use of microbial
platforms as a “green” and sustainable substitute for nanoparticle
synthesis (Nel et al., 2009; Siddiqi and Husen, 2016). Microbes
have a promising role in the fabrication of nanoparticles
due to their natural mechanism for detoxification of metal
ions through reduction that can be achieved in an extra-
or intracellular manner. Unlike nanoparticles derived from
physical and chemical methods, biogenic nanoparticles have
intrinsic protein capping and stabilizing agent on the surface
that confers rare physiological solubility and stability (Ahmad
et al., 2003). In addition to being eco-friendly, the emerging
microbial synthesis route is also economical owing to significant
reduction in downstream processing requirements. Inspired
by the microbe’s ability to function under divergent extremes
of temperature, pressure, and pH, several bacterial and algal
chassis have been explored over the last decade by several
groups, including our own laboratory (Nanda and Saravanan,
2009; Jain et al., 2011; Pantidos and Horsfall, 2014; Aziz et al.,
2015; Patel et al., 2015). Notably, fungal-derived nanoparticle
production shares these salient advantages and further combines
facile scale up opportunities, economic viability, convenient
processing and biomass handling, and faster biosynthesis rate
in cell-free filtrate (due to the higher amount of proteins
secreted in fungi with respect to bacteria) (Prasad et al., 2016).
Moreover, the presence of fungal mycelia provides an increased
surface area with the nanoparticles precipitated outside the cell
being devoid of unnecessary cellular components and therefore
amenable to direct use in applications of interest (Varshney et al.,
2012; Kitching et al., 2014). However, there are few systematic
studies that examine the potential synergism of fungal-derived
AgNP with antibiotics/fungicides across a diverse spectrum of
pathogenic microbial species.
In the present study, we demonstrate the antimicrobial
efficacy of AgNP derived from such a fungal chassis featuring
a representative member of the Mucorales species namely
Mucor hiemalis. To the best of our knowledge, this is the
first report employing the commonly occurring pathogenic
fungus M. hiemalis for AgNP synthesis, which is particularly
intriguing as this fungal species exhibits high growth rate
and is easy to harvest with less cultivation time. Our X-ray
diffraction (XRD) studies in conjugation with transmission
electron microscopy (TEM) reveal the crystalline nature and size
reproducibility of these biogenic nanoparticles. Furthermore, to
decipher the molecular structural information of the functional
moieties in the biosynthesized AgNP, Fourier transform
infrared spectroscopy (FTIR) experiments were carried out.
Importantly, we observe that these biogenic nanoparticles
display competitive antimicrobial activity (in relation to
established antibiotics) when incubated with different bacterial
(Gram-positive and Gram-negative) and fungal pathogens and
also show substantial synergistic effect when combined with
known antimicrobial agents in vitro. Collectively, our findings
offer an alternate fungal platform for production of silver
nanoparticle and pave the way for animal model studies to
examine the synergistic effect of the fungal-derived nanoparticle
and antibiotics in retarding and preventing microbial infections
in vivo.
MATERIALS AND METHODS
Chemicals and Microbes
All chemicals used in this study were of analytical grade,
procured from Sigma-Aldrich or Merck, India and used as
received. All culture media were purchased from HiMedia,
India. Double distilled water (ddH2O) or Milli-Q water
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was used for all the experiments in this study. For the
antimicrobial efficacy study, six bacterial strains namely
Klebsiella pneumoniae (KJ938546), Pseudomonas brassicacearum
(KJ938545), Aeromonas hydrophila (KM104684), Escherichia coli
(MCC 2412), Bacillus cereus (MCC 2243), and Staphylococcus
aureus (MCC 2408) were used. The first three strains were
procured from the Amity University (Noida, India), while the
latter three along with the fungal strain Candida albicans (MCC
1151) were received from the Microbial Culture Collection at
National Centre for Cell Science, Pune, India. Additionally,
Fusarium oxysporum (NFCCI 245), Aspergillus flavus (NFCCI
384), and Mucor hiemalis (NFCCI 2228) were procured
from National Fungal Culture Collection of India, Pune,
India.
Synthesis of AgNPs
Mucor hiemalis was grown on potato dextrose broth. Briefly,
the pH of the medium was adjusted to 5.1 ± 0.2 and flasks
were incubated at 180 rpm at 25◦C for 72 h. The pure culture
of M. hiemalis was maintained on potato dextrose agar (PDA)
slants at 4◦C. The mycelia were separated by centrifugation
(5000 rpm) for 10 min and filtered using Whatman filter
paper No. 1, and washed thrice with deionized water. After
washing, 100 ml of deionized water was added to 10 g of
wet fungal biomass and incubated for 48 h (180 rpm and
25◦C). After incubation, the mycelia were again centrifuged
(5000 rpm, 10 min) and filtered. Twenty milliliters of resulting
aqueous extract was diluted with 80 ml of water followed
by addition of 0.017 g (1 mM) silver nitrate (AgNO3)
in a conical flask and stirred at 25◦C in dark condition.
Control experiment without AgNO3 was also carried out under
identical conditions. After 24 h, visual observation revealed
a color change—from colorless to reddish brown due to
reduction of AgNO3 to AgNPs—of the fungal filtrate. Prior
to characterization, 100 ml of the nanoparticle solution was
centrifuged at 5000 rpm for 10 min. The supernatant was again
centrifuged at 10,000 rpm for 60 min to obtain a pellet. The
pellet was re-dispersed into 1 ml of deionized water (Kayalvizhi
et al., 2014). Centrifugation and re-dispersion in ddH2O were
repeatedly carried out to ensure better elimination of these
extraneous entities followed by lyophilization to obtain powdered
nanoparticles. The AgNP yield was determined by weighing the
powdered nanoparticles.
Nanoparticle Characterization
To examine the bioreduction of AgNO3 to AgNPs the
absorption spectra were recorded at different temporal points
using a double beam UV-Vis spectrophotometer (UV-1800,
Shimadzu, Japan). The surface morphology of the biogenic
AgNPs was characterized using scanning electron microscope
(SEM; Zeiss Evo HD, Jena, Germany) and energy dispersive
X-ray analysis (EDX, Oxford Instruments, UK) connected
with the SEM. Experiments with acquisition time ranging
from 60 to 100 s and an accelerating voltage of 20 kV was
performed to confirm the presence of elemental silver inside
the biologically synthesized nanoparticles. TEM (Philips, EM-
410LS, JEOL, Japan) was also used to observe the morphology
of the biosynthesized AgNPs. Acquired images were analyzed
using Image J (http://imagej.nih.gov/ij/download.html). For
microscopy observations, the sample was prepared by dispersing
5 mg of nanoparticles in 1 ml ethanol and the resulting
mixture was sonicated for 30 min. A small drop of the resulting
suspension was evenly spread on the grid followed by drying
at room temperature and the samples were gold-coated before
imaging. Additionally, for vibrational characterization, FTIR
measurements (Varian 7000 FTIR, USA) were performed on
the KBr pellet prepared with diluted AgNPs. Spectroscopic
measurements were carried out in 400–4000 cm−1 range at a
resolution of 4 cm−1. To evaluate the crystallinity of AgNPs, XRD
(Ultima IV, Rigaku, Japan) measurements were also performed
and the data was recorded at 2θ range of 20◦ to 80◦ having K-beta
filter with X-Ray of 1.54056 Å at 40 kV and 30 mA.
Antimicrobial Properties
Antibacterial and antifungal activities of AgNPs were evaluated
using agar well diffusion and disc diffusion method. To
determine the antibacterial activities of AgNPs, culture of four
Gram-negative bacteria namely Klebsiella pneumoniae (Kp),
Pseudomonas brassicacearum (Pb), Aeromonas hydrophila (Ah),
Escherichia coli (Ec) and two Gram-positive bacteria, namely
Bacillus cereus (Bc) and Staphylococcus aureus (Sa), were
prepared by growing a single colony overnight in nutrient broth
and adjusting the turbidity to 0.5 McFarland standards. Hundred
microliters of bacterial test pathogens were spread onto 25 ml
Mueller-Hinton agar medium in the plates. Fifty microliters of
different concentrations (5, 10, 20, and 30 µg/ml) of AgNPs
and 50 µl of 10 µg/ml antibiotics (streptomycin, tetracycline,
kanamycin, and rifampicin) were poured in the wells. Synergistic
effect of AgNPs with respective antibiotics was evaluated at
10 µg/ml concentration both for AgNPs and antibiotic. These
plates were incubated at 37◦C for 24 h and the zones of inhibition
were measured. All experiments were simultaneously performed
in triplicates.
The antifungal activity was assessed using agar well diffusion
method for Candida albicans while the disc diffusion method
was used for Fusarium oxysporum, and Aspergillus flavus. The
fungal spores were washed with sterile 0.85% saline containing
0.1% tween 80 (v/v). The spore suspension was adjusted
with sterile saline to a concentration of 1.0 × 107 spores/ml
in a final volume of 100 µl per well. The inocula were
stored at 4◦C for further use. Dilution of the inocula was
cultured on solid PDA to verify the absence of contamination
and to check the validity of the inoculum. 15, 30, 45, and
60 µg/ml concentrations of AgNPs and 30 µg/ml of standard
commercial fungicides [amphotericin B (A), fluconazole (F),
and ketoconazole (K)] were poured into Petri plates and their
growth inhibition was observed. Synergistic effect of AgNPs with
respective fungicides was measured at 30 µg/ml concentration of
the former. All experiments were simultaneously performed in
triplicates.
Antimicrobial Interaction Analysis
In order to assess the nature of the in vitro interactions between
any nanoparticle–drug combinations, the data obtained from the
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zone of inhibition studies were quantified using the following
equation:
I = I(A+B)
IA + IB (1)
Where I is the estimated interaction index, I(A+B) is zone of
inhibition for the combination of AgNP and antibiotic/fungicide,
IA is zone of inhibition of AgNPs alone and IB is zone
of inhibition for antibiotic/fungicide. While the interactions
are concentration dependent, since the concentrations of each
of these agents was kept constant (equal to 10 µg/ml and
30 µg/ml for the antibacterial and antifungal interaction
studies, respectively) the estimated interaction index in Eq. 1 is
concentration independent. Importantly, if the 95% confidence
intervals of I values of a combination of agents were significantly
higher or lower than 1, synergy or antagonism, respectively, was
concluded to be present for that particular combination.
Statistical Analysis
Data analysis was carried out using standard statistical software
GraphPad Prism. Descriptive statistical measures, especially the
mean and standard deviation, were used to summarize the
collection of data for each measurement. Two-way analysis of
variance was used to evaluate the influence of independent
variables as well as possible interactions between them in the
antimicrobial efficacy study. Tukey’s procedure was used to
determine whether the data show evidence of difference between
the various classes of antimicrobial agents.
RESULTS
Fungal-Derived AgNPs: Synthesis and
Characterization
Mucor hiemalis cultures were first grown in the potato dextrose
medium for 3 days (Figures 1A,B). Figure 1C displays the
representative microscopic morphology of the culture following
staining with lactophenol cotton blue stain. Incubation of the cell
extracts with 1 mM AgNO3 solution resulted in the formation
of AgNPs and we observed a steady color change of the solution
(Figure 1D). The formation of AgNPs was confirmed using
UV-Vis absorption measurements at different time intervals
(Figure 1E) with the spectrum obtained at 72 h displaying an
absorbance maximum at 420 nm. As seen in Figure 1F, the
peak intensity increases over time before plateauing around 72 h.
Here, we obtained ca. 45 mg/100 ml of AgNPs from the fungal
biosynthesis process and the quantity was consistent across three
repeats.
Figure 2A shows a representative SEM image of the
biologically synthesized AgNPs. On the region of interest
(highlighted by the magenta square in the figure), we performed
FIGURE 1 | (A) Colony morphology; (B) Mass culture of Mucor hiemalis; (C) Microscopic view of M. hiemalis processed with lactophenol cotton blue stain;
(D) Optical images of biosynthesized AgNP showing a range of colors from colorless (start of biosynthesis) to reddish-brown after 24 h; (E) UV-Vis spectra of
M. hiemalis-derived AgNPs at various reaction times; (F) Reaction saturation curve indicating the evolution of the absorption band as a function of time.
Frontiers in Microbiology | www.frontiersin.org 4 December 2016 | Volume 7 | Article 1984
fmicb-07-01984 December 15, 2016 Time: 11:17 # 5
Aziz et al. Synergistic Broad-Spectrum Antimicrobial Platform
FIGURE 2 | Morphological and chemical characterization of M. hiemalis-derived AgNP. (A) SEM image of biogenic AgNPs (scale bar indicates 4 µm);
(B) EDX spectrum of biogenic AgNPs; (C) TEM image of the biogenic AgNPs (scale bar indicates 100 nm); (D) histogram of the size distribution of biogenic AgNPs.
EDX measurement to determine the elemental composition
of the synthesized nanoparticles (Figure 2B). The measured
composition was consistent with the expected makeup with Ag
accounting for more than 90% of the compositional contributors
in the probed region (Supplementary Table S1). The remaining
content of carbon, oxygen, and sodium reflect the presence
of microbial biomolecules. To further investigate the size
distribution, we performed TEM analysis on the M. hiemalis-
derived AgNPs (Figure 2C). TEM images depict the spherical
morphology of the nanoparticles and the particle size distribution
was observed to vary in the range of 5–15 nm with only a very
small fraction of the particles having dimensions between 20 and
30 nm (Figure 2D).
As illustrated in the XRD graph of the biologically synthesized
AgNPs (Figure 3), four peaks at 2θ values of 38.3◦, 46.4◦, 63.9◦,
and 77.0◦ were observed corresponding to (111), (200), (220),
and (311) planes, respectively, of silver that were in agreement
with the standard powder diffraction card of Joint Committee
on Powder Diffraction, silver file No. 04-0783 (Yang et al., 2011).
The XRD results, thus, indicate that the synthesized nanoparticles
have a distinctly crystalline nature. We computed the mean size of
the ordered (crystalline) domains (D) using the Debye–Scherrer
formula:
D = 0.9λ/β cos θ
where λ represents the X-ray wavelength (0.1541 nm), β is the
line broadening at half the maximum intensity (equivalent to the
full width at half maximum (FWHM)) and θ is the Bragg’s angle.
Based on the different 2θ values, one can estimate a range of
average crystalline sizes that is consistent with the previous TEM
measurements of Figure 2D.
The FTIR spectra of the cell extract and the biologically
synthesized AgNPs are presented in Figure 4. The notable peaks
at 3312, 1661, and 1028 cm−1 in the FTIR spectrum of the extract
can be ascribed to the O–H stretching vibration of aromatic
compounds (such as phenols), C=C stretching vibration of
alkenes and C–N stretching, respectively. The features at 2928
and 2887 cm−1 can be ascribed C–H stretching vibrations,
whereas 1732 and 1553 cm−1 is likely indicative of C=O
stretching vibration of ketones and NH2 bending vibration of the
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FIGURE 3 | XRD spectrum showing the crystalline nature of the M. hiemalis-derived AgNPs. Further characterization details are included in Section
“Results.”
FIGURE 4 | FTIR spectra of (A) cell extract and (B) M. hiemalis-derived AgNPs.
primary amines, respectively. Furthermore, the bands at 1460,
1252, and 1155 cm−1 are consistent with peaks representative
of CH2 group bending, asymmetric PO2− stretching mode, and
C–O stretching mode of the C–OH groups of amino acids.
Notably, a gross inspection of Figures 4A,B reveals that the
FTIR spectrum of the AgNP solution is considerably less intense
and is broadened than that acquired from the cell extract. For
instance, the spectral bands at 2928 and 2887 cm−1 of the cell
extract is barely perceptible in the spectrum of the synthesized
AgNPs. Notably, reduction in the intensity of the 1028 cm−1
peak after biosynthesis of AgNPs suggests that one or more
cyclic peptides is involved in synthesizing and capping the
nanoparticles.
Antimicrobial Activity
To study the antibacterial efficacy, the biosynthesized AgNPs
were tested against six clinically significant pathogenic
bacteria, namely Klebsiella pneumoniae, Pseudomonas
brassicacearum, Aeromonas hydrophila, Escherichia coli,
Bacillus cereus, and Staphylococcus aureus. Fifty microliters
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of different concentrations of AgNPs were incubated
with the bacterial culture and the zone of inhibition was
observed for each case (Figures 5A–C). As evidenced
from Figures 5A–C, the biogenic nanoparticles display
consistent antibacterial action against all the types of
bacterial pathogens under consideration—even at a very
low concentration of 5 µg/ml. Expectedly, the size of inhibition
zone increases with the increase in AgNPs concentration
as verified through morphometric analysis of the cultures
(Figure 5B). The antibacterial activity of AgNPs was comparable
to the commercial antibiotics at the same concentration
(Figure 5C), albeit with variations in strength of action
of both the AgNP and the antibiotics across the bacterial
spectrum.
When AgNPs was mixed with above antibiotics in the same
concentration (ca. 10 µg/ml), a substantial increase in the
antibacterial activity was observed. To precisely elucidate the
nature of synergistic/antagonistic interactions, we computed
the interaction index for each combination from the zone of
inhibition studies. From Table 1, we observe that the order of
the degrees of synergistic interaction between these six species
was as follows: Pb > Ah > Ec > Bc > Sa > Kp. The
highest degree of synergy was found with the three Gram-
negative species, Pb, Ah, and Ec, especially for antibiotics
rifampicin (R) and streptomycin (S). Little synergy was
observed for Kp, even though it is also a Gram-negative
species.
The antifungal characteristic of the synthesized AgNP with
three representative fungi, namely Candida albicans (Ca),
Fusarium oxysporum (Fo), and Aspergillus flavus (Af) was
similarly tested and our observations are shown in Figure 6.
Morphometric analysis of the incubated cultures exhibits the
pattern of antifungal action with increasing concentration
of the nanoparticles (Figure 6B). The antifungal activity of
FIGURE 5 | Comparative analysis of antibacterial efficacy of M. hiemalis-derived AgNP. (A) Zone of inhibition against four Gram-negative bacterial
pathogens, Klebsiella pneumoniae (Kp), Pseudomonas brassicacearum (Pb), Escherichia coli (Ec), and Aeromonas hydrophila (Ah), and two Gram-positive bacterial
pathogens, Bacillus cereus (Bc) and Staphylococcus aureus (Sa); (B) Measurements of the antibacterial activity of AgNPs (NP) at 5, 10, 20, and 30 µg/ml
concentration against the six bacterial pathogens; and (C) Effect of biologically synthesized AgNPs (NP) and antibiotics [streptomycin (S), tetracycline (T), kanamycin
(K), and rifampicin (R)] used individually against the bacteria and in combination. The potential synergistic effect of biologically synthesized AgNPs with antibiotics
was investigated at a uniform 10 µg/ml concentration for all the agents. Experiments were performed in triplicates; mean ± SD are shown, the asterisk (∗) above the
error bar represents statistically significant differences between the action of the biogenic NPs and the control group (p-value < 0.05).
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TABLE 1 | Interaction indices for combination of AgNPs and antibiotics revealing the presence/absence of synergy in inhibiting bacterial growth.
Antibiotics Interaction Index
Klebsiella
pneumoniae (Kp)
Pseudomonas
brassicacearum
(Pb)
Aeromonas
hydrophila (Ah)
Escherichia coli
(Ec)
Bacillus cereus
(Bc)
Staphylococcus
aureus (Sa)
Streptomycin (S) 0.95 ± 0.02 2.00 ± 0.12 1.15 ± 0.05 1.17 ± 0.06 1.10 ± 0.06 1.04 ± 0.02
Tetracycline (T) 1.08 ± 0.03 1.26 ± 0.05 1.10 ± 0.02 1.13 ± 0.05 1.19 ± 0.06 1.17 ± 0.06
Kanamycin (K) 0.98 ± 0.02 1.03 ± 0.06 1.22 ± 0.06 1.14 ± 0.05 1.15 ± 0.04 1.07 ± 0.03
Rifampicin (R) 0.98 ± 0.05 1.25 ± 0.06 1.54 ± 0.12 1.54 ± 0.09 1.33 ± 0.09 1.35 ± 0.06
FIGURE 6 | Comparative analysis of antifungal efficacy of M. hiemalis-derived AgNP. (A) Zone of inhibition measured against three fungal pathogens:
Candida albicans (Ca), Fusarium oxysporum (Fo), Aspergillus flavus (Af); (B) Measurements of the antifungal activity of AgNPs (NP) at 15, 30, 45, and 60 µg/ml
concentration against the three pathogens; and (C) Effect of biologically synthesized AgNPs and fungicides [amphotericin B (A), fluconazole (F), and ketoconazole
(K)] used singly and in combination against the pathogenic fungi. All measurements were performed for a constant AgNP concentration of 30 µg/ml for commercial
fungicides. DMSO (dimethyl sulfoxide) (D) and fungal extract (FE) were employed as negative controls. Experiments were performed in triplicates; mean ± SD are
shown, the asterisk (∗) above the error bar represents statistically significant differences between the action of the biogenic NPs and the control group
(p-value < 0.05).
Frontiers in Microbiology | www.frontiersin.org 8 December 2016 | Volume 7 | Article 1984
fmicb-07-01984 December 15, 2016 Time: 11:17 # 9
Aziz et al. Synergistic Broad-Spectrum Antimicrobial Platform
TABLE 2 | Interaction indices for combination of AgNPs and fungicides
revealing the presence/absence of synergy in inhibiting fungal growth.
Fungicides Interaction Index
Candida
albicans (Ca)
Fusarium
oxysporum (Fo)
Aspergillus
flavus (Af)
Amphotericin B (A) 1.08 ± 0.05 1.04 ± 0.03 0.98 ± 0.05
Fluconazole (F) 1.07 ± 0.03 0.91 ± 0.06 1.08 ± 0.12
Ketoconazole (K) 1.04 ± 0.03 1.03 ± 0.09 1.04 ± 0.03
AgNPs was found to produce similar, if slightly smaller zones
of inhibition on average, in relation to that obtained with
standard fungicides, namely amphotericin B (A), fluconazole
(F), and ketoconazole (K), at the same concentration of
30 µg/ml (Figure 6C). Furthermore, when AgNPs was mixed
with commercial fungicides, a synergistic antifungal effect was
reflected for some combinations. The order of the average degrees
of positive interaction between these three species was as follows:
Ca > Af > Fo (Table 2).
DISCUSSION
Mucor hiemalis, a common soil fungus of phylum zygomycota,
is well known for producing a diverse array of enzymes and
lipids (Wang, 1967; Leck, 1999). Based on its rapid growth
and ability to withstand a wide spectrum of environmental
conditions, we reasoned that M. hiemalis can be leveraged as
a microbial platform for AgNP synthesis by seizing the Ag+
ions from the AgNO3 environment and reducing the ions into
their elemental form with the help of the enzymes generated
through cellular activities supported by Prasad et al. (2016).
Extracellular secretion of enzymes is especially advantageous for
large-scale nanoparticle synthesis and isolation of nanoparticles
produced. The formation and size of AgNPs were also elucidated
by observing the surface plasmon resonance peak. The increase
in reaction time of AgNPs synthesis results in corresponding
blue shifts of the absorption peak, which reflects decrease in the
size of the nanoparticles with reaction time, the same condition
was also stated by Pandey et al. (2012). Characterization through
SEM with EDX revealed consistency in elemental composition
of the synthesized nanoparticle. TEM and XRD revealed that
the nanoparticles were spherical in shape, crystalline, and well-
controlled. It is worth noting that the possibility of aggregate
formation of AgNPs, akin to other metal nanoparticles, may
lead to functional modifications. The latter can be investigated
by quantifying colony formation after incubation in presence
of AgNPs in liquid culture and forms an important feature
of our ongoing efforts to better understand their antimicrobial
properties.
A salient feature of, and often the driving rationale for, a
fungal chassis is the intrinsic faster biosynthesis rate in cell-
free filtrate as fungi secrete large quantities of extracellular
redox proteins capable of reducing metal ions to their insoluble
form and subsequently to nanocrystals. It is well established
that the high level of enzymes and proteins secreted not only
improve the yield but also impart greater stability to the
biogenic nanoparticle (Rai et al., 2009). Here, our FTIR findings
show the presence of such stabilizing agents and also help
identify the biomolecules responsible for Ag+ ions reduction
to Ag0. This finding is not unexpected, as literature reports
have consistently observed proteins capping and stabilizing the
surface of biogenic nanoparticle (Ahmad et al., 2003; Rai et al.,
2009).
Antimicrobial Activity
The antimicrobial properties of silver are well established and,
thus, it has been extensively utilized in the medical field (Wright
et al., 1999; Fu et al., 2006). In this study, we first sought to test
the relative efficacy of the biogenic nanoparticles, derived from
M. hiemalis, against a wide spectrum of bacteria and fungi, with
respect to the action of commercial antibiotics and fungicides.
To study the antibacterial efficacy, the biosynthesized AgNPs
were tested against six clinically significant pathogenic bacteria.
This cohort was selected to present a challenging and demanding
subsets of Gram-positive and Gram-negative bacteria for testing
antimicrobial efficacy. This action has been previously explained
through a combination of interference with the respiratory chain
at the cytochromes (Bragg and Rainnie, 1974) as well as with
components of the bacterial electron transport system (Feng
et al., 2000), binding DNA and inhibiting its replication (Modak
and Fox, 1973).
The antibacterial activity of AgNPs was comparable to
the commercial antibiotics at the same concentration, albeit
with variations in strength of action of both the AgNPs and
the antibiotics across the bacterial spectrum. Additionally, the
relative efficacy of the singly used AgNPs was more prominent
in the Gram-negative pathogens. Studies by Rhim et al. (2006)
and Huang et al. (2011) have spawned similar observations,
presumably owing to the thinner cell walls of the Gram-
negative strains leading to facile perforation and more rapid
absorption. When AgNPs was mixed with above antibiotics in
the same concentration (ca. 10 µg/ml), a substantial increase
in the antibacterial activity was observed. To precisely elucidate
the nature of synergistic/antagonistic interactions, we computed
the interaction index for each combination from the zone of
inhibition studies. The degree of synergy was lower, on balance,
with Gram-positive pathogens reflective of the absence of outer
membrane permeability barriers in such bacteria. Collectively,
this highlights the presence of synergistic interactions for a
large fraction of the AgNPs and antibiotic combinations (rather
than simply additive effects) opening the door for combined
action against multi-drug resistant strains. This is particularly
important in view of the increasing epidemic of drug-resistant
pathogens, as several bacteria have developed resistance against
conventional antibiotics. It is also notable that biologically
synthesized AgNPs have previously shown better synergistic
effects as compared to chemically derived AgNPs (Hari et al.,
2014). This is attributable to the differential capping of biogenic
and chemically synthesized nanoparticles, and is consistent with
reports of the direct impact of silver nanomaterial capping on
antibiotic sensitive and resistant strains of bacteria (Tiwari et al.,
2015).
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One plausible explanation for the enhanced antibacterial
activity using a combination of AgNP and antibiotics is the
bonding between the nanoparticles and antibiotic molecules. The
active functional groups of antibiotics such as hydroxyl and
amino groups, can be chelated by silver and thereby cover a
considerable portion of the surface of AgNPs (Morones-Ramirez
et al., 2013). Alternately, the findings can also be driven by the
AgNP-induced reactive oxygen species generation that increases
the cell permeability, which in turn stimulates the antibiotic
action (Fayaz et al., 2010).
In relation to the antifungal activity, the degree of synergy
was lowest with Fusarium oxysporum, reflecting the characteristic
of the constituents present on the surface of the fungi causing
permeability barriers. While the synergy in most combinations
was found to be statistically significant, it is worth noting that the
degree of synergy was not as strong as that noted in some of the
antibacterial studies.
CONCLUSION
In the quest for advanced topical ointments, wound healing
bandages and coated stents with superior resistance to microbial
infections, nanosilver formulations have surfaced as an attractive
option. With an increasing focus on less toxic and cleaner
synthesis methods that require minimal downstream processing,
we report here a fungal platform, M. hiemalis, which facilitates
rapid and large-scale production of well-controlled AgNPs.
Characterization of these biogenic NPs highlights not only their
crystalline nature but also reveals the presence of capping and
stabilizing proteins on the surface thereby enabling its direct use
for antimicrobial coatings. In our study, we also observed that
these NPs show competitive inhibitory effect on a broad spectrum
of pathogenic bacteria and fungi in relation to antibiotics and
fungicides, which cannot (individually) mimic the action against
both set of pathogens. Furthermore, the AgNPs combined with
the antibiotics and fungicides have a significant synergistic effect
on these species. Overall, these findings underscore the promise
of the M. hiemalis derived AgNPs, and provide the scientific
foundation for translational studies in animal models.
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